Brazil-based medical diagnostic company Centro de Imagem Diagnosticos (Alliar) has raised a total of BRL766 million (approximately US$243 million) in its IPO on Novo Mercado, a segment of BM&F BOVESPA. Alliar is backed by Brazil-focused private equity firm Patria Investimentos and Kinea, the alternative asset management arm of Brazil-based bank Itau Unibanco. Kinea disposed of shares in the offering, while Patria did not dispose of any shares.